Bg pattern

XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Xevudy 500 mg concentrate for solution for infusion

sotrovimab

This medicinal product is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of section 4 will tell you how to report side effects.

Read all of this leaflet carefully before you are given this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Xevudy and what is it used for
  2. What you need to know before you are given Xevudy
  3. How Xevudy is given
  4. Possible side effects
  5. Storage of Xevudy
  6. Contents of the pack and other information

1. What is Xevudy and what is it used for

Xevudy contains the active substance sotrovimab. Sotrovimab is a monoclonal antibody, a type of protein modified to recognize a specific target on the SARS-CoV-2 virus, the virus that causes COVID-19.

Xevudy is used to treat COVID-19 in adults and adolescents (from 12 years of age and weighing at least 40 kg). It targets the spike protein that the virus uses to attach to cells, preventing the virus from entering the cell and producing new viruses. By preventing the virus from multiplying in the body, Xevudy can help your body overcome the infection and prevent serious illness.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given Xevudy

You must not be given Xevudy

  • if you are allergic to sotrovimab or any of the other ingredients of this medicine (listed in section 6).
  • Tell your doctorif you think this applies to you.

Warnings and precautions

Allergic reactions

Xevudy can cause allergic reactions.

  • See "Allergic reactions" in Section 4.

Infusion-related reactions

Xevudy can cause infusion-related reactions.

  • See "Infusion-related reactions" in Section 4.

Children and adolescents

Xevudy must not be given to children or adolescents under 12 years of age or weighing less than 40 kg.

Other medicines and Xevudy

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnantor are planning to have a baby, ask your doctorfor advice before being given Xevudy. Your doctor will decide if the benefits of treatment with Xevudy outweigh the potential risks to you and your baby.

It is not knownif the components of Xevudy can pass into breast milk. If you are breastfeeding, ask your doctorfor advice before being given Xevudy.

Driving and using machines

Xevudy is not expected to affect your ability to drive or use machines.

Xevudy contains polysorbate

This medicine contains 4.8 mg of polysorbate 80 in each 500 mg dose. Polysorbates may cause allergic reactions. Tell your doctor if you have any known allergy.

3. How Xevudy is given

The recommended dose for adults and adolescents (12 years of age or older and weighing at least 40 kg) is:

  • 500 mg (one vial)

The medicine will be prepared in a solution and given to you by drip (infusion) into a vein by a doctor or nurse. It takes up to 30 minutes to give you the full dose of the medicine. You will be monitored during and for at least 1 hour after the treatment.

The "Instructions for healthcare professionals" below provide details for your doctor, pharmacist or nurse on how to prepare and administer the infusion of Xevudy.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Allergic reactions

Allergic reactions to Xevudy are commonand affect up to 1 in 10 people.

Rarely, these allergic reactions can be serious (anaphylaxis), affecting up to 1 in 1,000 people (rare). If you get any of the following symptoms after being given Xevudy, you may be having an allergic reaction and should seek medical help immediately:

  • skin rash, like hives or redness of the skin
  • itching
  • swelling, sometimes of the face or mouth (angioedema)
  • increased wheezing (high-pitched sound when breathing), cough or difficulty breathing
  • sudden feeling of weakness or dizziness (which can cause loss of consciousness or falls)

Infusion-related reactions

It is commonfor infusion-related reactions to occur when receiving an infusion, affecting up to 1 in 10 people. These reactions usually develop within minutes or hours but can appear up to 24 hours after treatment or later. The following symptoms are possible. If you get any of these symptoms after being given Xevudy, you may be having an infusion-related reaction and should seek medical help immediately:

  • redness of the skin (flushing)
  • chills
  • fever
  • difficulty breathing
  • fast heart rate
  • low blood pressure

Other side effects

Uncommon (may affect up to 1 in 100 people)

  • shortness of breath (dyspnoea).

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Xevudy

Healthcare professionals are responsible for storing this medicine and disposing of any unused product correctly.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of the month shown.

Do not freeze.

Before dilution:

  • store in a refrigerator (2°C to 8°C)
  • store in the original package to protect from light.

Once diluted, this medicine should be used immediately. If immediate administration is not possible after dilution, the diluted solution can be stored at room temperature (up to 25°C) for up to 6 hours or in a refrigerator (2°C to 8°C) for up to 24 hours from the time of dilution until administration is complete.

6. Contents of the pack and other information

What Xevudy contains

  • The active substance is sotrovimab. Each vial contains 500 mg of sotrovimab in 8 ml of concentrate.
  • The other ingredients are histidine, histidine hydrochloride, sucrose, polysorbate 80 (E 433) (see section 2 "Xevudy contains polysorbate"), methionine and water for injections.

Appearance and pack

Xevudy is a clear, colourless or yellow to brown liquid presented in a single-use glass vial with a rubber stopper and a removable aluminium seal. Each pack contains one vial.

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited

12 Riverwalk

Citywest Business Campus

Dublin 24

D24 YK11

Ireland

Manufacturer

GlaxoSmithKline Manufacturing S.p.A.

Strada Provinciale Asolana, 90,

43056 San Polo di Torrile, Parma

Italy

You can request more information about this medicine from the local representative of the marketing authorisation holder:

België/Belgique/Belgien

GlaxoSmithKline Pharmaceuticals s.a./n.v.

Tél/Tel: + 32 (0) 10 85 52 00

Lietuva

GlaxoSmithKline Trading Services Limited

Tel: + 370 80000334

Text in Bulgarian language with contact information of GlaxoSmithKline Trading Services Limited and phone number

Luxembourg/Luxemburg

GlaxoSmithKline Pharmaceuticals s.a./n.v.

Belgique/Belgien

Tél/Tel: + 32 (0) 10 85 52 00

Ceská republika

GlaxoSmithKline, s.r.o.

Tel: + 420 222 001 111

[email protected]

Magyarország

GlaxoSmithKline Trading Services Limited.

Tel: + 36 80088309

Danmark

GlaxoSmithKline Pharma A/S

Tlf.: + 45 36 35 91 00

[email protected]

Malta

GlaxoSmithKline Trading Services Limited.

Tel: + 356 80065004

Deutschland

GlaxoSmithKline GmbH & Co. KG

Tel.: + 49 (0)89 36044 8701

[email protected]

Nederland

GlaxoSmithKline BV

Tel: + 31 (0)33 2081100

Eesti

GlaxoSmithKline Trading Services Limited.

Tel: + 372 8002640

Norge

GlaxoSmithKline AS

Tlf: + 47 22 70 20 00

Ελλάδα

GlaxoSmithKline Μονοπρ?σωπη A.E.B.E.

Τηλ: + 30 210 68 82 100

Österreich

GlaxoSmithKline Pharma GmbH

Tel: + 43 (0)1 97075 0

[email protected]

España

GlaxoSmithKline, S.A.

Tel: + 34 900 202 700

[email protected]

Polska

GSK Services Sp. z o.o.

Tel.: + 48 (0)22 576 9000

France

Laboratoire GlaxoSmithKline

Tél: + 33 (0)1 39 17 84 44

[email protected]

Portugal

GlaxoSmithKline – Produtos Farmacêuticos, Lda.

Tel: + 351 21 412 95 00

[email protected]

Hrvatska

GlaxoSmithKline Trading Services Limited

Tel: +385 800787089

România

GlaxoSmithKline Trading Services Limited

Tel: + 40800672524

Ireland

GlaxoSmithKline (Ireland) Limited

Tel: + 353 (0)1 4955000

Slovenija

GlaxoSmithKline Trading Services Limited

Tel: + 386 80688869

Ísland

Vistor ehf.

Sími: + 354 535 7000

Slovenská republika

GlaxoSmithKline Trading Services Limited

Tel: + 421 800500589

Italia

GlaxoSmithKline S.p.A.

Tel: + 39 (0)45 7741111

Suomi/Finland

GlaxoSmithKline Oy

Puh/Tel: + 358 (0)10 30 30 30

Κ?προς

GlaxoSmithKline Trading Services Limited

Τηλ: + 357 80070017

Sverige

GlaxoSmithKline AB

Tel: + 46 (0)8 638 93 00

[email protected]

Latvija

GlaxoSmithKline Trading Services Limited

Tel: + 371 80205045

Date of last revision of this leaflet

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu, and on the Spanish Agency of Medicines and Health Products (AEMPS) web site (http://www.aemps.gob.es/).

-------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals.

For more information, see the Summary of Product Characteristics.

Treatment should be prepared by a qualified healthcare professional using aseptic technique.

Traceability

In order to improve the traceability of biological medicinal products, the name and batch number of the administered product should be clearly recorded.

Preparation of the dilution

  1. Remove a vial of sotrovimab from the refrigerator (2°C to 8°C). Allow the vial to reach room temperature, protected from light, for approximately 15 minutes.
  2. Visually inspect the vial to ensure it is free from particles and that there is no visible damage to the vial. If the vial is identified as unusable, discard it and restart preparation with a new vial.
  3. Gently rotate the vial in circles several times before use without creating air bubbles. Do not shake or vigorously agitate the vial.

Dilution instructions

  1. Withdraw and discard 8 ml from a 50 ml or 100 ml infusion bag containing 9 mg/ml (0.9%) sodium chloride solution for infusion or 5% glucose solution for infusion.
  2. Withdraw 8 ml of sotrovimab from the vial.
  3. Inject the 8 ml of sotrovimab into the infusion bag through the septum.
  4. Discard any unused solution remaining in the vial. The vial is for single use only and should only be used for one patient.
  5. Before infusion, gently move the infusion bag back and forth 3 to 5 times. Do not invert the infusion bag. Avoid the formation of air bubbles.

The diluted sotrovimab solution should be used immediately. If immediate administration is not possible after dilution, the diluted solution can be stored at room temperature (up to 25°C) for up to 6 hours or in a refrigerator (2°C to 8°C) for up to 24 hours from the time of dilution until administration is complete.

Administration instructions

  1. Connect an infusion set to the infusion bag using a standard diameter tube. It is recommended to administer the dosing solution intravenously with an in-line filter of 0.2 μm.
  2. Prepare the infusion set.
  3. Administer as an intravenous infusion over 15 minutes (when using a 50 ml infusion bag) or 30 minutes (when using a 100 ml infusion bag) at room temperature.

Disposal

Disposal of unused medicinal product and all materials that have come into contact with it should be done in accordance with local regulations.

Online doctors for XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION

Discuss questions about XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (33)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (32)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€0
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION?
XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION?
The active ingredient in XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION is sotrovimab. This information helps identify medicines with the same composition but different brand names.
Who manufactures XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION?
XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION is manufactured by Glaxosmithkline Trading Services Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION?
Other medicines with the same active substance (sotrovimab) include BEYFORTUS 100 mg injectable solution in pre-filled syringe, BEYFORTUS 50 mg Injectable Solution in Pre-filled Syringe, EVUSHELD 150 MG +150 MG INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media